Recent HR Stock Price | HR Stock Predictions | |
$14.03 | +20.38% |
$16.89 |
Recent HR Analyst Ratings Breakdown, Making HR Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 3 | 3 | 3 | 5 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 8 | 8 | 9 | 6 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.45 | 2.45 | 2.5 | 2.09 |
For the HR stock predictions from the analysts covering Healthcare Realty Trust Incorporated, we have collected all of the individual HR stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 9 different analysts covering HR (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since HR stock predictions may vary widely, another useful metric to consider is the median HR stock prediction, which represents the price at which half of the analysts
made HR stock predictions that were higher and half made HR stock predictions that were lower. This makes for a different take on the HR stock predictions out there, as compared to average or mean.
And that median across all the individual HR stock predictions was: $17.0 as of 2024-04-26.
The very highest of the HR stock predictions for one year price target was $20.0, while the very lowest of the HR stock predictions in the analyst group was
$15.0 (with a standard deviation of $1.536). Get the latest Zacks research report on HR — FREE
Find out: HR next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
GIII Stock Predictions
BNED Stock Predictions
CPRI Stock Predictions
POOL Stock Predictions
AWI Stock Predictions
NEPH Stock Predictions
RBB Stock Predictions
SPOT Stock Predictions
KAMN Stock Predictions
|
HR Next Dividend Date » (Projection based upon history) HR Dividend Growth Rate » Quotes delayed 20 minutes |
Buy (2.55 out of 4) 14th percentile
(ranked lower than approx. 86% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |